Our site uses cookies to offer a better navigation functionality, including "third party" cookies and "profiling cookies" designed to send on-line commercial communications in line with the preferences expressed by the user while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here to disable them. Upon proceeding with browsing this website, you will be consenting to the use of cookies.

Event in Florence 24-02-2011

Under the auspices of:

Comune di Firenze

Università

Provincia_Firenze

MENARINI RESEARCH: TODAY’S VALUES, TOMORROW’S CHALLENGES

A conference organized to celebrate the 125th anniversary of the Menarini Group

Thursday, February 24, 2011

Florence, Palazzo Vecchio – Salone dei Cinquecento

The year 2011 marks the 125th anniversary of the founding of Menarini. Menarini began its research activities in 1978, building from scratch its scientific know-how (knowledge) and drug development abilities (the skills). Thanks to this dedication and commitment, in the 1990’s it began registering its new drugs for the treatment of cardiovascular disease, infectious disease, and pain. Today Menarini has over 700 employees in Research and Development. Along this continuing journey, Menarini has welcomed many young Italian researchers who, unable to find career solutions in public research, would have otherwise contributed to the country’s brain drain.

Program

Chairmen
ENRICO GARACI
President of the Higher Institute of Health – Rome

GIANFRANCO GENSINI
Dean of the School of Medicine, University of Florence

Welcome
MATTEO RENZI
Mayor of the city of Florence

Company’s Opening Address
Video “125 Years of Menarini”

CARLO ALBERTO MAGGI
Director of Research for the Menarini Group
Today’s Values and Tomorrow’s Challenges for MENARINI Research

LOUIS J. IGNARRO
Nobel Prize Laureate in Medicine and Physiology
Professor of Molecular and Medical Pharmacology
U.C.L.A., Los Angeles, California – U.S.A.
Nitric Oxide: The Road to Stockholm

JONATHAN S. BEREK
Professor and Chair, Obstetrics and Gynaecology
Stanford Women’s Cancer Center, Stanford University School of Medicine,
Stanford, California – U.S.A.
Abagovomab, the Immunotherapy for Ovarian Cancer: Can We Increase Survival?

ANGELA CAPRIATI
Director of Clinical Research for the Menarini Group
From Protocol to Clinical Trials: The Commitment of Menarini Research in the MIMOSA Project

DOMENICO REGOLI
Department of Clinical and Experimental Medicine, University of Ferrara
Italian Research on Neuropeptides: An Area of Excellence

ANDREW SLADE
President of Menarini Biotech
Focus on Biotechnology

SERGIO DOMPE’
President of Farmindustria
Closing Remarks

“Menarini: A Century of History, Research at the International Level”
Louis J. Ignarro

Download the program in PDF format:

Fondazione Menarini

 

Enter the Fondazione Internazionale Menarini site.

GO TO SITE »

Our values

 

10 core values have influenced the progress of our group.

READ MORE »

Diagnostics

 

Advanced Technology

READ MORE »

Quality first

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »